David Plotnik

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Topics

Placebo Controlled

Top Venues

Antimicrobial agents and chemotherapy

Journal of virology

This page only lists publications with an associated author ORCID identifier.

Publications

David Plotnik, Jennifer E Sager, Madhukar Aryal, Marie C Fanget, Alessia Peter, Michael A Schmid, Deborah Cebrik, Erik Mogalian, Keith Boundy, Wendy W Yeh, Paul Griffin, Maribel Reyes
A phase 1 study in healthy volunteers to investigate the safety, tolerability, and pharmacokinetics of VIR-2482: a monoclonal antibody for the prevention of severe influenza A illness. Antimicrobial agents and chemotherapy 68 (4) (2024)
David Plotnik, Jennifer E Sager, Madhukar Aryal, Marie C Fanget, Alessia Peter, Michael A Schmid, Deborah Cebrik, Erik Mogalian, Keith Boundy, Wendy W Yeh, Paul Griffin, Maribel Reyes
A phase 1 study in healthy volunteers to investigate the safety, tolerability, and pharmacokinetics of VIR-2482: a monoclonal antibody for the prevention of severe influenza A illness. Antimicrobial agents and chemotherapy (2024)
David Plotnik, Jennifer E Sager, Madhukar Aryal, Marie C Fanget, Alessia Peter, Michael A Schmid, Deborah Cebrik, Erik Mogalian, Keith Boundy, Wendy W Yeh, Paul Griffin, Maribel Reyes
A phase 1 study in healthy volunteers to investigate the safety, tolerability, and pharmacokinetics of VIR-2482: a monoclonal antibody for the prevention of severe influenza A illness. Antimicrobial agents and chemotherapy 68 (4) (2024)
David Plotnik, Jennifer E Sager, Madhukar Aryal, Marie C Fanget, Alessia Peter, Michael A Schmid, Deborah Cebrik, Erik Mogalian, Keith Boundy, Wendy W Yeh, Paul Griffin, Maribel Reyes
A phase 1 study in healthy volunteers to investigate the safety, tolerability, and pharmacokinetics of VIR-2482: a monoclonal antibody for the prevention of severe influenza A illness. Antimicrobial agents and chemotherapy 68 (4) (2024)
David Plotnik, Jennifer E Sager, Madhukar Aryal, Marie C Fanget, Alessia Peter, Michael A Schmid, Deborah Cebrik, Erik Mogalian, Keith Boundy, Wendy W Yeh, Paul Griffin, Maribel Reyes
A phase 1 study in healthy volunteers to investigate the safety, tolerability, and pharmacokinetics of VIR-2482: a monoclonal antibody for the prevention of severe influenza A illness. Antimicrobial agents and chemotherapy (2024)
David Plotnik, Wenjin Guo, Brad Cleveland, Priska von Haller, Jimmy K Eng, Miklos Guttman, Kelly K Lee, James Arthos, Shiu-Lok Hu
Extracellular Matrix Proteins Mediate HIV-1 gp120 Interactions with α4β7. Journal of virology 91 (21) (2017)